Supplemental Annuity Collective Trust (SACT) of New Jersey’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
WT
Supplemental Annuity Collective Trust (SACT) of New Jersey's EW Position: Q2 2026 in Review
Supplemental Annuity Collective Trust (SACT) of New Jersey reduced its Edwards Lifesciences (EW) stake by 6% in Q2 2026, selling an estimated $19.8K and leaving 3,693 shares worth $334K. The position accounts for 0.09% of the portfolio, ranked #224.
Supplemental Annuity Collective Trust (SACT) of New Jersey first reported a position in EW in Q4 2019 and has held it in 26 quarters since. The position peaked at $583K in Q4 2021. 973 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Supplemental Annuity Collective Trust (SACT) of New Jersey held 3,693 shares of Edwards Lifesciences worth $334K as of Q2 2026.
- Supplemental Annuity Collective Trust (SACT) of New Jersey sold 236 Edwards Lifesciences shares in Q2 2026, an estimated $19.8K.
- Edwards Lifesciences made up 0.09% of Supplemental Annuity Collective Trust (SACT) of New Jersey's portfolio in Q2 2026, its #224 holding.
- Supplemental Annuity Collective Trust (SACT) of New Jersey first reported a position in Edwards Lifesciences in Q4 2019 and has held it in 26 quarters since.
- Supplemental Annuity Collective Trust (SACT) of New Jersey's Edwards Lifesciences position peaked at $583K in Q4 2021.
- 973 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Supplemental Annuity Collective Trust (SACT) of New Jersey's 13F filing for Q2 2026, filed 27 Jul 2026.